The Pharma & MedTech industry is one of the most dynamic in the world. Expected to grow at nearly six percent annually over the next few years, change in the industry is fast becoming the norm. With constant change comes opportunity to progress, however women are still heavily unrepresented at a senior level, despite accounting for 60% of the overall workforce.
The Advancing Women’s Leadership in Pharma & MedTech Summit will help you overcome barriers to success faced by women. Learn how to navigate a successful career in a turbulent industry, stand out for opportunities, develop key leadership skills, make your value more visible and overcome various career obstacles.
Benefits of attending
- Build better relationships to underpin your career
- Manage through change associated with market globalisation & technological developments
- Transition from a technical specialist to a generalist leader
- Create your own opportunities to foster career success
- Develop a work/life balance that works for you
Who will attend?
Current and aspiring female leaders from Pharma, MedTech and Medical Devices, with roles and responsibilities for:
- Heads of Division
- Regional/National Manager
- Senior Management
- Clinical Operations/Scientific Manager
- Laboratory/Research Manager
- Sales and Account Management
- Team Leader
Attend to learn:
- Stand out for leadership opportunities
- Lead in an industry experiencing rapid & disruptive change
- Overcome obstacles & seize opportunities for career growth
- Be an impactful & authentic leader
Maurice Ben-Mayor has more than 20 years of experience in the Medical Technology sector. He is president for Stryker SouthPacific, a position he has held since 2015. Prior to this, Maurice spent seven years serving in a number of director roles within Stryker’s sales and marketing divisions. Maurice originally joined Stryker as a marketing manager in 2003. Prior to Stryker, Maurice worked as a sales representative for medical devices company, Synthes.
Maurice is passionate about innovative technology, developing people and building high-performing cultures. Maurice holds a Bachelor of Science (Psychology) and an MBA, both from The University of New South Wales. He is also a current board member of the Medical Technology Association of Australia.
With a career spanning more than 20 years, Karen is currently the Country Chair for Sanofi Australia and New Zealand, and the General Manager of the company’s Australia & New Zealand General Medicines business.
Karen’s strengths span the areas of transformational change, navigation and management of complex business issues and a sizeable knowledge and expertise in healthcare sales and marketing. Her experience has seen her lead teams through industry, environmental and organisational change. She is also an expert across the pharmaceutical product lifecycle from launch, to growth and later stage marketing.
In recent years Karen has overseen the Australian delivery of a number of major global acquisitions and integrations. She has also delivered large scale structural and organisational initiatives, for the business, in support of Sanofi’s global Roadmap. Since becoming Country Chair, Karen has focused on cross business collaboration and integration to drive growth.
Karen is a passionate proponent of the healthcare industry, its commitment to patients and the ability of her team members to be equipped to deliver on their shared purpose each day. She is also a strong advocate for women in leadership and an active member of Sanofi’s Women in Leadership Council for the Japan and Pacific Region.
Melinda Munns joined the pharmaceutical industry over 20 years ago after completing a PhD in Pharmacology in Melbourne Australia and a Post Doctorate Research Fellowship in London. Melinda worked at the Global Headquarters of Ipsen in London as a manager in their global clinical research program after which she took the opportunity to assist with the opening of the Australian subsidiary, leading clinical and medical projects. This led to a total tenure of 11 years with Ipsen. Subsequently, she joined Sanofi to manage an MSL team across 5 therapeutic areas. Melinda then took an unusual step to extend her managerial and operational skills by taking a role as a GM for an IT start-up company followed by a role as Global COO for a HR software company. During this time she completed her MBA. The need to make a difference for patients, led her back to pharma where she has thoroughly enjoyed the role as Associate Medical Director, Integrated Oncology followed by a promotion to Medical Director, Australia and New Zealand at Bristol-Myers Squibb.
Johnson & Johnson